Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

clinical benefit

- PMLiVE

Developing drugs to conquer cancer

Future treatments for suppression of antitumour activity, metastatic melanoma and NSCLC were showcased at ASCO 2012 with some exciting results

- PMLiVE

J&J to launch ‘innovation centres’ in US, UK and China

Will target local life sciences partnerships in early-stage innovation

- PMLiVE

UK pharma ‘must prove value’ to the NHS

Facing unprecedented financial pressures, it is imperative companies continue to evolve

- PMLiVE

Driving early clinical and commercial alignment

Real-world studies can provide evidence to ensure that your brand resonates with your customers

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links